✦ LIBER ✦

Introduction: CML in the imatinib era

✍ Scribed by R. Hehlmann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Questioning the aim of CML therapy in th

✍ Carella, A M 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 76 KB

Imatinib resistance in CML

✍ Gisella Volpe; Cristina Panuzzo; Stefano Ulisciani; Daniela Cilloni 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Excellent outcomes of children with CML

✍ Hideki Muramatsu; Yoshiyuki Takahashi; Hirotoshi Sakaguchi; Akira Shimada; Nobuh 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 250 KB

Imatinib mesylate beneficial in CML

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 150 KB

Impact of timing of allogeneic stem cell

✍ M. Schleuning; D. Judith; I. Burlakova; H. Baurmann; R. Schwerdtfeger 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Prognostic factors for outcomes in allog

✍ Khoury, H J; Kukreja, M; Goldman, J M; Wang, T; Halter, J; Arora, M; Gupta, V; R 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 331 KB